돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 383781생성일: 2026년 10월 26일

Pyrazole → 3-(1-{[2-(1H-pyrazol-1-yl)-3',5'-bis(trifluoromethyl)biphenyl-4-yl]carbonyl}pyrrolidin-3-yl)pyridine

https://huagongshe.com/reaction/383781

반응식

참여 물질

역할이름HCID투입량
반응물PyrazoleHCID 1048—
반응물Salicylaldehyde oximeHCID 7200—
반응물Cesium carbonateHCID 10796—
반응물3-(1-{[2-Bromo-3',5'-bis(trifluoromethyl)biphenyl-4-yl]carbonyl}pyrrolidin-3-yl)pyridineHCID 86657753—
촉매HCID 178419072HCID 178419072—
용매AcetonitrileHCID 6342—
생성물3-(1-{[2-(1H-pyrazol-1-yl)-3',5'-bis(trifluoromethyl)biphenyl-4-yl]carbonyl}pyrrolidin-3-yl)pyridineHCID 46847591—

반응 단계

A solution of 3b (54.0 mg, 0.099 mmol), pyrazole (50.7 mg, 0.745 mmol), salicylaldoxime (19.8 mg, 0.145 mmol), copper(I) oxide (16.6 mg, 0.116 mmol) and cesium carbonate (265 mg, 0.812 mmol) in acetonitrile (1.00 mL) was heated to 120° C. in a sealed microwave vial for a total of 60 min. The reaction mixture was cooled to rt, concentrated in vacuo, and the resulting crude residue was purified by preparative reversed phase HPLC on YMC Pack Pro C18 stationary phase (CH3CN/H2O as eluent, 0.05% TFA as modifier), followed by lyophilization of the purified fractions to afford the title compound 10a. m/z (ES) 531 (MH)+.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US08367679B2
출처 데이터셋uspto-grants-2013_02
ORD IDord-a453bc123ad646129051bb5ef7295e14
출처 메모uspto-grants-2013_02